Nature Cell acquires approval of Phase 1/2 clinical trials for dementia treatment from US FDA
Clinical trials to treat American Alzheimer’s disease patients with stem cells manufactured in Korea were approved by the U.S. FDA.
Nature Cell(CEO Jung-Chan La) announced it acquired approval of the Astrostem’s Phase 1 & 2 clinical trial plans applied on the 21st of October for Alzheimer’s dise...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
